TUFN yields 15.46% · JNJ yields 2.13%● Live data
📍 TUFN pulled ahead of the other in Year 1
Combined, TUFN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TUFN + JNJ for your $10,000?
Tufin Software Technologies Ltd., together with its subsidiaries, develops, markets, and sells software-based solutions primarily in the United States, Israel, Europe, the Middle East, and Africa, Germany, the Asia Pacific, and internationally. The company provides SecureTrack, which enables security administrators to define and manage a centralized security policy, minimize the attack surface, and ensure continuous compliance across the network; SecureChange that is used to assess, provision, and verify security configuration changes across physical networks and cloud platforms, while maintaining security and compliance; and SecureApp, which is used to define, manage, and monitor network connectivity for their applications. It also offers SecureCloud, a security policy management service for cloud-native, multi-cloud, and hybrid-cloud applications and workloads. In addition, the company provides vulnerability mitigation app that enables organizations to prioritize remediation?and mitigation?efforts by enhancing vulnerability scanner output with network insights. It sells its products and services through distributors and resellers, as well as service delivery partners. Tufin Software Technologies Ltd. was incorporated in 2005 and is headquartered in Tel Aviv, Israel.
Full TUFN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.